Edition:
India

People: DexCom Inc (DXCM.OQ)

DXCM.OQ on NASDAQ Stock Exchange Global Select Market

158.36USD
10:31pm IST
Change (% chg)

$3.01 (+1.94%)
Prev Close
$155.35
Open
$155.76
Day's High
$160.09
Day's Low
$155.10
Volume
50,415
Avg. Vol
333,948
52-wk High
$178.45
52-wk Low
$105.05

Leach, Jake 

Mr. Jake Steven Leach is Executive Vice President, Chief Technology Officer of the Company. He has served as our Executive Vice President, Chief Technology Officer since October 2018, and previously served as our Senior Vice President of Research and Development from January 2015 to October 2018, and previously served as our Vice President of Research and Development from January 2011 to January 2015. From February 2010 to January 2011, he served as our Senior Director of Research and Development, from September 2008 to February 2010, he served as our Director of Research and Development, from January 2007 to February 2010 he served as our Manager of Hardware Engineering, and from March 2004 to January 2007 as Senior Electrical Engineer. From 1996 to 2004, Jake held positions in research and development at MiniMed and subsequently Medtronic Diabetes, focusing on the development of glucose sensing systems. Mr. Leach holds a Bachelor of Science degree in Electrical Engineering with a minor in Biomedical Engineering from the University of California, Los Angeles.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kevin Sayer

9,554,120

Quentin Blackford

3,391,640

Jake Leach

--

Donald Abbey

2,919,160

Andrew Balo

3,174,640

Richard Doubleday

3,207,460
As Of  31 Dec 2018